Changes in cardiac electrical biomarker with hyperaemic stress: an experimental perspective.

Back

ESC Professional Premium Access

Changes in cardiac electrical biomarker with hyperaemic stress: an experimental perspective.

Session: Preclinical and clinical laboratory markers in chronic coronary syndromes

Topic: Chronic Ischaemia

Speaker: Doctor F. Adjei (Stevenage, GB)

Event: ESC Congress 2023

Congress Presentation

About the speaker

Doctor Felicia Adjei

East and North Hertfordshire NHS Trust, Stevenage (United Kingdom of Great Britain & Northern Ireland)

0 follower

6 more presentations in this session

CSL112 (apolipoprotein A-I [human]) reduces the elevation in neutrophil-lymphocyte ratio (NLR) induced by acute myocardial infarction

Speaker: Professor B. Kingwell (Melbourne, AU)

Soluble urokinase Plasminogen Activator Receptor (suPAR) is associated with educational attainment in patients with coronary artery disease

Speaker: Mr D. Fueller (Atlanta, US)

Fibroblast growth factor 23 is a strong independent marker of poor outcome after an acute coronary syndrome

Speaker: Doctor A. Kallmeyer (Madrid, ES)

Acute exposure to PM2.5 promotes arterial stiffening by down-regulating serine and trans-4-hydroxyproline dependent pathways - results from an Asutralian cohort metabolomic study

Speaker: Doctor S. Fathieh (Sydney, AU)

Formation of denser plasma fibrin clots is associated with coronary artery ectasias and aneurysms - preliminary results from the CARE-ANEURYSM study

Speaker: Doctor J. Chmiel (Krakow, PL)

Access the full session

Preclinical and clinical laboratory markers in chronic coronary syndromes

Speakers: Doctor F. Adjei, Professor B. Kingwell, Mr D. Fueller, Doctor A. Kallmeyer, Doctor S. Fathieh...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

Changes in cardiac electrical biomarker with hyperaemic stress: an experimental perspective.

About the speaker

Doctor Felicia Adjei

6 more presentations in this session

CSL112 (apolipoprotein A-I [human]) reduces the elevation in neutrophil-lymphocyte ratio (NLR) induced by acute myocardial infarction

Soluble urokinase Plasminogen Activator Receptor (suPAR) is associated with educational attainment in patients with coronary artery disease

Fibroblast growth factor 23 is a strong independent marker of poor outcome after an acute coronary syndrome

Acute exposure to PM2.5 promotes arterial stiffening by down-regulating serine and trans-4-hydroxyproline dependent pathways - results from an Asutralian cohort metabolomic study

Formation of denser plasma fibrin clots is associated with coronary artery ectasias and aneurysms - preliminary results from the CARE-ANEURYSM study

Access the full session

Preclinical and clinical laboratory markers in chronic coronary syndromes

About the event

ESC Congress 2023

ESC 365 is supported by